Juan Eduardo Megías-Vericat

27PUBLICATIONS
62CO-AUTHORS
Rheumatology and arthritisNanomedicineHaematologyImmunogenetics (incl. genetic immunology)Biomechanics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Oct 28, 2025
Real-World Assessment of Pharmacokinetics, Clinical Outcomes, and Costs After Switching from Standard Half-Life to Extended Half-Life FVIII in Well-Controlled Hemophilia A Patients.

Maria Choví-Trull, Juan Eduardo Megías-Vericat, Santiago Bonanad-Boix

|Aug 30, 2025
Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia.

Antonio Solana-Altabella, Carles Iniesta-Navalón, Maria Chovi-Trull

|Jul 18, 2025
Budget impact analysis of Haemate-P as long-term prophylaxis and on-demand therapy for von Willebrand disease in Spain.

Michele R Wilson, Pablo Mendez, Cheryl L McDade

|Mar 07, 2025
Cost-effectiveness and cost-utility analysis of Haemate-P versus other von Willebrand disease treatments in Spain.

Juan E Megias-Vericat, Gines Escolar, Michele R Wilson

|Feb 26, 2025
Pharmacogenetics in Response to Biological Agents in Inflammatory Bowel Disease: A Systematic Review.

Octavio Ballesta-López, Mayte Gil-Candel, María Centelles-Oria

|Mar 12, 2024
Benefits of physical activity self-monitoring in patients with haemophilia: a prospective study with one-year follow-up.

Sofía Pérez-Alenda, Juan J Carrasco, Felipe Querol-Fuentes

Pageof 5

Frequent Collaborators

14 joint publications

Pau Montesinos

13 joint publications

David Martínez-Cuadrón

12 joint publications

Antonio Solana-Altabella

9 joint publications

Octavio Ballesta-López